We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
GNC Holdings (GNC) Q2 Earnings: Disappointment in the Cards?
Read MoreHide Full Article
GNC Holdings, Inc. (GNC - Free Report) , a specialty retailer of health and nutrition related products, is scheduled to report second-quarter 2017 results on Jul 27, before the opening bell.
Last quarter, the company posted a positive earnings surprise of 12.1%. However, GNC Holdings’ trailing four-quarter earnings average lagged the Zacks Consensus Estimate by 20.5%.
Let’s see how things are shaping up prior to this announcement.
Factors at Play
GNC Holdings' last reported first-quarter 2017 adjusted earnings per share (EPS) reflected a massive 46.4% year-over-year deterioration. Revenues in the quarter dropped 3.6% year over year. The dismal performance was primarily due to lower sales at the U.S. & Canada international and manufacturing/wholesale segments. Also, in the first quarter of 2017, gross margin and adjusted operating margin deteriorated. Hence, we expect a similar trend in the second quarter of 2017 as well.
Moreover, GNC Holdings has a number of tough competitors in the market that include large international pharmacy chains, major international supermarket firms and large U.S.-based companies with global operations. Thus, we expect the company to slash product prices in the face of stiff competition, which, in turn, may hurt margins.
Also, currency headwinds continue to be a growing concern for GNC Holdings. Management also expects the failure to comply with FTC regulations and changing consumer preferences to hamper business.
However, on the bright side, the performance of One New GNC was quite encouraging during the first quarter of 2017. Banking on it, we expect the company to continue to gain in the yet-to-be-reported quarter. Meanwhile, the launch of the PRO Access program has added members to the company’s customer base, which is expected to drive growth.
Earnings Whispers
Our proven model does not conclusively show an earnings beat for GNC Holdings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here, as you will see below.
Zacks ESP: GNC Holdings has an Earnings ESP of 0.00%. That is because both the Most Accurate estimate and the Zacks Consensus Estimate are pegged at 39 cents. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: GNC Holdings has a Zacks Rank #4 (Sell). Please note that we caution against stocks with a Zacks Rank #4 or 5 (Strong Sell) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Here are a few companies you may want to consider as our proven model shows that they have the right combination of elements to post an earnings beat this quarter:
Align Technology, Inc. (ALGN - Free Report) has an Earnings ESP of +1.37% and a Zacks Rank #2.
Stryker Corporation (SYK - Free Report) has an Earnings ESP of +0.66% and a Zacks Rank #2.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look. See the pot trades we're targeting>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
GNC Holdings (GNC) Q2 Earnings: Disappointment in the Cards?
GNC Holdings, Inc. (GNC - Free Report) , a specialty retailer of health and nutrition related products, is scheduled to report second-quarter 2017 results on Jul 27, before the opening bell.
Last quarter, the company posted a positive earnings surprise of 12.1%. However, GNC Holdings’ trailing four-quarter earnings average lagged the Zacks Consensus Estimate by 20.5%.
Let’s see how things are shaping up prior to this announcement.
Factors at Play
GNC Holdings' last reported first-quarter 2017 adjusted earnings per share (EPS) reflected a massive 46.4% year-over-year deterioration. Revenues in the quarter dropped 3.6% year over year. The dismal performance was primarily due to lower sales at the U.S. & Canada international and manufacturing/wholesale segments. Also, in the first quarter of 2017, gross margin and adjusted operating margin deteriorated. Hence, we expect a similar trend in the second quarter of 2017 as well.
GNC Holdings, Inc. Price and EPS Surprise
GNC Holdings, Inc. Price and EPS Surprise | GNC Holdings, Inc. Quote
Moreover, GNC Holdings has a number of tough competitors in the market that include large international pharmacy chains, major international supermarket firms and large U.S.-based companies with global operations. Thus, we expect the company to slash product prices in the face of stiff competition, which, in turn, may hurt margins.
Also, currency headwinds continue to be a growing concern for GNC Holdings. Management also expects the failure to comply with FTC regulations and changing consumer preferences to hamper business.
However, on the bright side, the performance of One New GNC was quite encouraging during the first quarter of 2017. Banking on it, we expect the company to continue to gain in the yet-to-be-reported quarter. Meanwhile, the launch of the PRO Access program has added members to the company’s customer base, which is expected to drive growth.
Earnings Whispers
Our proven model does not conclusively show an earnings beat for GNC Holdings this quarter. That is because a stock needs to have both a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) for this to happen. That is not the case here, as you will see below.
Zacks ESP: GNC Holdings has an Earnings ESP of 0.00%. That is because both the Most Accurate estimate and the Zacks Consensus Estimate are pegged at 39 cents. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: GNC Holdings has a Zacks Rank #4 (Sell). Please note that we caution against stocks with a Zacks Rank #4 or 5 (Strong Sell) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Stocks to Consider
Here are a few companies you may want to consider as our proven model shows that they have the right combination of elements to post an earnings beat this quarter:
Becton, Dickinson and Company (BDX - Free Report) has an Earnings ESP of +0.41% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Align Technology, Inc. (ALGN - Free Report) has an Earnings ESP of +1.37% and a Zacks Rank #2.
Stryker Corporation (SYK - Free Report) has an Earnings ESP of +0.66% and a Zacks Rank #2.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look. See the pot trades we're targeting>>